Cargando…
Editorial: Cardiomyopathies: Current Treatment and Future Options
Cardiomyopathies are an essential component in clinical cardiology. The number of different cardiomyopathies have increased a lot due to genetics and newer insights in pathomechanism. The current treatment and future options are demonstrated in advance.
Autor principal: | Peters, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693478/ https://www.ncbi.nlm.nih.gov/pubmed/33142802 http://dx.doi.org/10.3390/jcm9113531 |
Ejemplares similares
-
Arrhythmogenic Cardiomyopathy—Current Treatment and Future Options
por: Migliore, Federico, et al.
Publicado: (2021) -
Fabry Cardiomyopathy: Current Treatment and Future Options
por: Vardarli, Irfan, et al.
Publicado: (2021) -
Treatment of Transthyretin Amyloid Cardiomyopathy: The Current Options, the Future, and the Challenges
por: Tschöpe, Carsten, et al.
Publicado: (2022) -
Hypertrophic Cardiomyopathy—Current Challenges and Future Perspectives
por: Monda, Emanuele, et al.
Publicado: (2023) -
RBM20-Related Cardiomyopathy: Current Understanding and Future Options
por: Koelemen, Jan, et al.
Publicado: (2021)